Posted on December 8th, 2011 by
Mayo clinic researchers have discovered a combination of drugs that seem to be effective at killing 70 percent of cancer cells that are resistant to chemotherapy. The drug was a combination of ixabepilone and sunitinib – two drug which had not previous been used together. This combination could be a good option for the treatment of late-stage ovarian cancer.
ThirdAge, by Emily Jacobson, 12/7/11
You must be logged-in to the site to post a comment.